These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29931415)

  • 1. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk.
    Tosur M; Geyer SM; Rodriguez H; Libman I; Baidal DA; Redondo MJ;
    Diabetologia; 2018 Sep; 61(9):2043-2053. PubMed ID: 29931415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
    Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
    Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription Factor 7-Like 2 (
    Redondo MJ; Steck AK; Sosenko J; Anderson M; Antinozzi P; Michels A; Wentworth JM; Atkinson MA; Pugliese A; Geyer S;
    Diabetes Care; 2018 Dec; 41(12):2480-2486. PubMed ID: 30275285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated Progression to Type 1 Diabetes in the Presence of
    Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
    Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
    Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
    Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
    J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
    Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
    J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
    Ferrara-Cook C; Geyer SM; Evans-Molina C; Libman IM; Becker DJ; Gitelman SE; Redondo MJ;
    Diabetes Care; 2020 Mar; 43(3):580-587. PubMed ID: 31937610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
    Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
    JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
    Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
    Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
    Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.
    Thomas NJ; Walkey HC; Kaur A; Misra S; Oliver NS; Colclough K; Weedon MN; Johnston DG; Hattersley AT; Patel KA
    Diabetologia; 2023 Feb; 66(2):310-320. PubMed ID: 36355183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk.
    Nucci AM; Virtanen SM; Cuthbertson D; Ludvigsson J; Einberg U; Huot C; Castano L; Aschemeier B; Becker DJ; Knip M; Krischer JP;
    Diabetologia; 2021 Apr; 64(4):826-835. PubMed ID: 33474583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising the age-dependent effects of risk factors on type 1 diabetes progression.
    So M; O'Rourke C; Ylescupidez A; Bahnson HT; Steck AK; Wentworth JM; Bruggeman BS; Lord S; Greenbaum CJ; Speake C
    Diabetologia; 2022 Apr; 65(4):684-694. PubMed ID: 35041021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity for premature stop codon of the MHC class I chain-related gene A (MIC-A) is associated with early activation of islet autoimmunity of DR3/4-DQ2/8 high risk DAISY relatives.
    Ide A; Babu SR; Robles DT; Wang T; Erlich HA; Bugawan TL; Rewers M; Fain PR; Eisenbarth GS
    J Clin Immunol; 2005 Jul; 25(4):303-8. PubMed ID: 16133985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
    Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
    Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
    Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
    Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.